fda warning letters glp-1 october 2025 news Democratic lawmakers are pressing the Trump administration to disclose who received special access to Eli Lilly's investigational obesity drug retatrutide. Sen. Maggie Hassan (D-N.H.) sent a letter to HHS Secretary Robert F FDA warnings against compounded GLP-1s
Description
Plan coverage and prior authorization are required for all weight-loss medications
doi: 10.1016/j.peptides.2014.01.020
For the complete shelf-life discussion by peptide, see BPC-157 Storage Temperature and Shelf Life and Peptide Storage Guide
Metabolic health improvements: 98% of patients improved at least one metabolic marker, and 78% of those with prediabetes or diabetes normalized their hemoglobin A1c levels at 12 months
The study used the Massachusetts General Hospital-Sexual Functioning Questionnaire (MGH-SFQ) to assess sexual desire in 24 volunteers, ages 18 to 50
